Electronic Informed Consent for Clinical Trials: Why, What and How
This webinar will present an exploration of trends that are leading to adoption of e-consent; options are available for e-consent, what is involved in implementing e-consent. A live demonstration of an e-consent will set the stage for implementation questions.
Why Should You Attend : Why are you considering e-consent:
- Lack of patient interest in trial participation
- Need for greater patient involvement during trial
- Need to explain complex terms and protocol
- Need to implement remote monitoring
What concerns you the most:
Areas Covered in the Session
- Reaction of the IRB
- FDA non-acceptance of the consents
- Patient inability to use technology
- Lack of acceptance by clinical staff
Who Will Benefit:
- Using an e-consent to assist low literacy patient populations understand your trial
- Using e-consent to assist patients in understanding their role in a complex clinical trial.
- Working with an IRB in the review of a e-consent
- Understanding the cost drivers of an e-consent process
- Features of an e-consent. Deciding what is important to your trial.
- Clinical trial Innovation teams
- VP, Clinical trials
- Clinical Operations (VP, Senior Managers, Trial Managers)
- IT innovation leads
- Managers, VPs Research Portfolios